Anna Rudenko
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- SARS-CoV-2 and COVID-19 Research 1
- Journals
- The Lancet (3 papers)
In The Last Decade
Anna Rudenko
3 papers receiving 852 citations
Anna Rudenko's Hit Papers
Peers
Comparison fields: 5 of 84
- Infectious Diseases 558
- Applied Microbiology and Biotechnology 45
- Internal Medicine 56
- Neurology 185
- Obstetrics and Gynecology 40
Countries citing papers authored by Anna Rudenko
This map shows the geographic impact of Anna Rudenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rudenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rudenko more than expected).
Fields of papers citing papers by Anna Rudenko
This network shows the impact of papers produced by Anna Rudenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rudenko. The network helps show where Anna Rudenko may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
About Anna Rudenko
Anna Rudenko is a scholar working on Infectious Diseases, Insect Science, Renewable Energy, Sustainability and the Environment, Obstetrics and Gynecology and Anesthesiology and Pain Medicine, having authored 3 papers that have together received 896 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Infectious Diseases (558 citations), Applied Microbiology and Biotechnology (45 citations), Internal Medicine (56 citations), Neurology (185 citations) and Obstetrics and Gynecology (40 citations). Anna Rudenko has collaborated with scholars based in Indonesia, Nepal and Australia. Their work appears in journals such as The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.